SAVANNAH, GA–(Marketwired – Mar 10, 2014) – MIT Holding, Inc. (OTCQB: MITD) announced today that Curaspan Health Group awarded a “Renewed Annual Referral Central Network for Patient Transitions” contract. This will allow MIT and its future acquisitions to market on a real-time basis the compound pharmaceuticals, infusion services and durable medical equipment directly to the patients of over 5,400 Curaspan medical facilities.
Recognized as the industry leader, Curaspan in 1999 was the first company to automate the on-demand creation of targeted, comprehensive online referral packets. Curaspan connects providers, payers and suppliers via secure electronic patient-transition networks to improve outcomes as patients move between levels of care.
Walter Drakeford, MITD’s CEO, stated, “MIT Holding turned to Curaspan because of its one of a kind industry reputation. Curaspan leads its competitors in nearly every category used by KLAS to rate transition planning solutions.
“The alliance is a double win for MIT first our cost to acquire the patient will be one of the lowest in the industry, while increasing staff efficiencies. The training of Curaspan systems only requires 2.5 hours of classroom for staff.
“The second win passes through to the acquisition targets of MIT. Any acquisition doing business in any given geographic location, will be able to market all MIT product lines into every geographic locations MIT Holding is licensed. Creating an ‘overnight’ product depth and economic edge on their local competitors.”
Curaspan Health Group (www.curaspan.com) is a national provider of secure Health Information Exchange and Patient Transition software and services. The company’s software and web-based services enable healthcare organizations to increase revenues, improve productivity, and reduce cost by eliminating the paper and manual work-flow steps from the clinical and administrative responsibilities while ensuring regulatory compliance. The company’s web-based applications are delivered as Software as a Service (SaaS) to its customers. Its flexible platform and interoperability with the leading HIS vendors (Meditech, McKesson, Cerner, Eclypsis, ACS-Midas+ and Epic) allow for a seamless integration and a rapid, cost effective deployment.
With its focus on customer support, client satisfaction, and strong ROI, Curaspan has realized an industry-leading 98% customer retention rate throughout its ten-year history. Curaspan’s client base includes many of the leading health care providers in the country including New York Presbyterian Health System, Dartmouth Hitchcock Alliance, Johns Hopkins Health System, Partners Healthcare, Medstar Health System and Sentara Healthcare System.
For more information, contact Mr. William Nalley, Orsay Groupe, firstname.lastname@example.org, phone 305-790-2688 and/or visit http://www.mitholdingsinc.com/home-2.
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate